Other Information
+Added: On May 1, 2023 , Michael Weening , President and Chief Executive Officer of the Company, adopted a Rule 10b5-1 trading arrangement (the “10b5-1 Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
+Added: The 10b5-1 Plan allows for the contemporaneous exercise of options and sale of up to 284,000 shares of Common Stock, at specific market prices, commencing on July 31, 2023, and continuing until all such options are exercised and the underlying shares are sold, or April 30, 2025, whichever comes first.
Number Description
7 unchanged sentences
333-163252) and incorporated by reference).
−Removed: 10.1* Consulting Agreement between Calix, Inc.
−Removed: and Michael Everett dated March 30, 2023.
+Added: 10.1* Calix, Inc.
+Added: Non-Employee Director Cash Compensation Policy, as amended February 9, 2023.
+Added: 10.2* Calix, Inc.
+Added: Non-Employee Director Equity Compensation Policy, as amended February 9, 2023.
31.1 Certification of Chief Executive Officer of Calix, Inc.
13 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: April 24, 2023 By:
+Added: July 24, 2023 By:
/s/ Michael Weening
2 unchanged sentences
(Principal Executive Officer)
−Removed: April 24, 2023 By:
+Added: July 24, 2023 By:
/s/ Cory Sindelar
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.